Adar1-Capital-Management

AI_NATIVE detailed information: This accession holds the following tickers:[
  "JWN",
  "MRUS",
  "AKRO",
  "KNSA",
  "ASND",
  "EWTX",
  "CNTA",
  "NKTR",
  "INSM",
  "RVMD",
  "TIL",
  "ARGX",
  "AQN",
  "EXAS",
  "MDGL",
  "APLS",
  "ARWR",
  "PTCT",
  null,
  null,
  null,
  "IROH",
  null,
  null,
  null,
  null,
  null,
  null,
  "ABVX",
  null,
  "DVAX",
  "MREO",
  "RGNX",
  "RXRX",
  "SWTX",
  "RCKT",
  "ARVN",
  "ATXS",
  "TNGX",
  "GPCR",
  "SLN",
  "SVRA",
  "THRD",
  "TSHA",
  "ACHV",
  "NRIX",
  "STOK",
  "SMMT",
  "TECX",
  "MLYS",
  "KYMR",
  "PHAT",
  "NMRA",
  "KROS",
  "ADGM",
  "ABOS",
  "NGNE",
  "SAGE",
  "ALEC",
  "ALDX",
  "AVTX",
  "AMLX",
  "JANX",
  "AVR",
  "BIOA",
  "PHGE",
  "BOLT",
  "CLRB",
  null,
  null,
  "CTNM",
  "ESTA",
  "GERN",
  "SRRK",
  "FULC",
  "SYRE",
  "APGE",
  "ISRG",
  "ABUS",
  null,
  null,
  "KALA",
  "KRRO",
  "KALV",
  "LPTX",
  "LXEO",
  null,
  "MNPR",
  "NXTC",
  "OABI",
  "OVID",
  "OKUR",
  "RLYB",
  "PRQR",
  "QNCX",
  "PMVP",
  "RNXT",
  "SPRO",
  "SEPN",
  "STTK",
  "SGRY",
  "IOVA",
  null,
  null,
  null,
  null,
  "IKT",
  "TARA",
  "RZLT",
  "NVS",
  "TEVA",
  null,
  "ZYME",
  "ZURA",
  null,
  null,
  "OGN",
  "PFE",
  null,
  null,
  null,
  "REGN",
  null,
  null,
  "UPB",
  "RAPT",
  "PTGX",
  "PEPG",
  "AGIO",
  "AVXL",
  null,
  "SLDB",
  "TENX",
  "LYRA",
  "RYTM",
  "MLTX",
  "SLNO",
  "ACLX",
  null,
  "ETNB",
  "DYN",
  "ARDX",
  "CKPT",
  "SPRB",
  "TXMD",
  "GOSS",
  "SRPT",
  "NTRA",
  "WVE",
  "ROIV",
  null,
  null,
  "CNTB",
  "CNTX",
  "CDTX",
  "ELDN",
  "DCTH",
  null,
  "IMNM",
  "ITOS",
  "INZY",
  "KURA",
  "KZR",
  null,
  "VRNA",
  "VTYX",
  "VTGN",
  "VKTX",
  "VIR",
  "VRDN",
  "VYNE",
  "VYGR",
  "XENE",
  "XLO",
  "ZLAB",
  "XNCR",
  "ORKA",
  "BIIB",
  "BHVN",
  null,
  "IMVT",
  null,
  "PCVX",
  "BCRX",
  "BNTX",
  "BMRN",
  "BBIO",
  "CRGX",
  "CLDX",
  "CGON",
  "CLOV",
  "CRNX",
  "DAWN",
  "CTMX",
  "CYTK",
  "DNLI",
  "DNTH",
  "LLY"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 198
Total Value: 523731625
Accession Number: 0001940272-25-000003
Form Type: 13F-HR
CIK: adar1-capital-management
Manager Name: Adar1-Capital-Management

Data Enrichment

82% identified

163 identified35 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

198 positions • $523.7M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 1 of 10

Sort by:

Protagonist Therapeutics, Inc

PTGX|74366E102

Shares:939.7K

Value:$45.4M

% of Portfolio:8.7% ($45.4M/$523.7M)

02072L565

Shares:337.1K

Value:$37.6M

% of Portfolio:7.2% ($37.6M/$523.7M)

Roivant Sciences Ltd.

ROIV|G76279101

Shares:3.5M

Value:$35.1M

% of Portfolio:6.7% ($35.1M/$523.7M)

Zai Lab Ltd

ZLAB|98887Q104

Shares:940.9K

Value:$34.0M

% of Portfolio:6.5% ($34.0M/$523.7M)

Immunovant, Inc.

IMVT|45258J102

Shares:968.9K

Value:$16.6M

% of Portfolio:3.2% ($16.6M/$523.7M)

CYTOKINETICS INC

CYTK|23282W605

Shares:390.7K

Value:$15.7M

% of Portfolio:3.0% ($15.7M/$523.7M)

Keros Therapeutics, Inc.

KROS|492327101

Shares:1.5M

Value:$15.1M

% of Portfolio:2.9% ($15.1M/$523.7M)

Abivax S.A.

ABVX|00370M103

Shares:2.2M

Value:$13.8M

% of Portfolio:2.6% ($13.8M/$523.7M)

78468R663

Shares:135.6K

Value:$12.4M

% of Portfolio:2.4% ($12.4M/$523.7M)

BridgeBio Pharma, Inc.

BBIO|10806X102

Shares:339.6K

Value:$11.7M

% of Portfolio:2.2% ($11.7M/$523.7M)

Inhibikase Therapeutics, Inc.

IKT|45719W205

Shares:5.1M

Value:$11.2M

% of Portfolio:2.1% ($11.2M/$523.7M)

464287457

Shares:103.3K

Value:$8.5M

% of Portfolio:1.6% ($8.5M/$523.7M)

TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA|881624209

Shares:523.8K

Value:$8.1M

% of Portfolio:1.5% ($8.1M/$523.7M)

Sarepta Therapeutics, Inc.

SRPT|803607100

Shares:122.9K

Value:$7.8M

% of Portfolio:1.5% ($7.8M/$523.7M)

G70077105

Shares:750.0K

Value:$7.7M

% of Portfolio:1.5% ($7.7M/$523.7M)

CG Oncology, Inc.

CGON|156944100

Shares:301.1K

Value:$7.4M

% of Portfolio:1.4% ($7.4M/$523.7M)

RAPT Therapeutics, Inc.

RAPT|75382E109

Shares:6.0M

Value:$7.3M

% of Portfolio:1.4% ($7.3M/$523.7M)

Janux Therapeutics, Inc.

JANX|47103J105

Shares:264.9K

Value:$7.2M

% of Portfolio:1.4% ($7.2M/$523.7M)

Arbutus Biopharma Corp

ABUS|03879J100

Shares:1.9M

Value:$6.6M

% of Portfolio:1.3% ($6.6M/$523.7M)

46116X101

Shares:48.0K

Value:$6.3M

% of Portfolio:1.2% ($6.3M/$523.7M)

Instrument	Shares		Other Manager	Value	% of Portfolio
Protagonist Therapeutics, Inc(PTGXcusip74366E102)	939.7K	QoQ +611.87% (+807.7K) YoY +19.60% (+154.0K)	All Managers (Combined)	$45.4M	8.7% ($45.4M/$523.7M)	QoQ +791.86% (+$40.3M) YoY +99.93% (+$22.7M)
(cusip02072L565)✕	337.1K	QoQ +3.58% (+11.7K) YoY +5.97% (+19.0K)	All Managers (Combined)	$37.6M	7.2% ($37.6M/$523.7M)	QoQ +4.72% (+$1.7M) YoY +10.98% (+$3.7M)
Roivant Sciences Ltd.(ROIVcusipG76279101)	3.5M	QoQ -0.72% (-25.3K) YoY +24.76% (+691.5K)	All Managers (Combined)	$35.1M	6.7% ($35.1M/$523.7M)	QoQ -15.32% (-$6.4M) YoY +19.44% (+$5.7M)
Zai Lab Ltd(ZLABcusip98887Q104)	940.9K	QoQ -10.03% (-105.0K) YoY +4176.62% (+918.9K)	All Managers (Combined)	$34.0M	6.5% ($34.0M/$523.7M)	QoQ +24.14% (-$6.6M) YoY +9547.77% (+$33.7M)
Immunovant, Inc.(IMVTcusip45258J102)	968.9K	QoQ +23.03% (-181.4K) YoY +1494.49% (+908.1K)	All Managers (Combined)	$16.6M	3.2% ($16.6M/$523.7M)	QoQ -15.11% (-$2.9M) YoY +743.39% (+$14.6M)
CYTOKINETICS INC(CYTKcusip23282W605)	390.7K	QoQ +2487.60% (+375.6K) YoY +15529.16% (+388.2K)	All Managers (Combined)	$15.7M	3.0% ($15.7M/$523.7M)	QoQ +2110.79% (+$15.0M) YoY +8859.29% (+$15.5M)
Keros Therapeutics, Inc.(KROScusip492327101)	1.5M	QoQ +6294.48% (+1.5M) YoY +339.46% (-1.1M)	All Managers (Combined)	$15.1M	2.9% ($15.1M/$523.7M)	QoQ +4016.22% (+$14.8M) YoY -32.35% (-$7.2M)
Abivax S.A.(ABVXcusip00370M103)	2.2M	QoQ +46.03% (+696.6K) YoY +14633.46% (+2.2M)	All Managers (Combined)	$13.8M	2.6% ($13.8M/$523.7M)	QoQ +24.68% (+$2.7M) YoY +6339.44% (+$13.6M)
(cusip78468R663)✕	135.6K	QoQ +2.88% (+3.8K) YoY +317.18% (+103.1K)	All Managers (Combined)	$12.4M	2.4% ($12.4M/$523.7M)	QoQ +3.22% (+$388.0K) YoY +316.86% (+$9.5M)
BridgeBio Pharma, Inc.(BBIOcusip10806X102)	339.6K	QoQ -49.96% (-339.2K) YoY +28202.91% (+338.4K)	All Managers (Combined)	$11.7M	2.2% ($11.7M/$523.7M)	QoQ -36.96% (-$6.9M) YoY +31543.97% (+$11.7M)
Inhibikase Therapeutics, Inc.(IKTcusip45719W205)	5.1M	QoQ +0.37% (-19.1K) YoY NEW(+5.1M)	All Managers (Combined)	$11.2M	2.1% ($11.2M/$523.7M)	QoQ -32.36% (-$5.4M) YoY NEW(+$11.2M)
(cusip464287457)✕	103.3K	QoQ NEW(+103.3K) YoY NEW(+103.3K)	All Managers (Combined)	$8.5M	1.6% ($8.5M/$523.7M)	QoQ NEW(+$8.5M) YoY NEW(+$8.5M)
TEVA PHARMACEUTICAL INDUSTRIES LTD(TEVAcusip881624209)	523.8K	QoQ +257.10% (+377.1K) YoY +415.38% (+422.1K)	All Managers (Combined)	$8.1M	1.5% ($8.1M/$523.7M)	QoQ +149.03% (+$4.8M) YoY +461.40% (+$6.6M)
Sarepta Therapeutics, Inc.(SRPTcusip803607100)	122.9K	QoQ +207.28% (+82.9K) YoY +10143.41% (+121.7K)	All Managers (Combined)	$7.8M	1.5% ($7.8M/$523.7M)	QoQ +61.28% (+$3.0M) YoY +4949.70% (+$7.7M)
(cusipG70077105)✕	750.0K	QoQ 0.00% (+0) YoY NEW(+750.0K)	All Managers (Combined)	$7.7M	1.5% ($7.7M/$523.7M)	QoQ +1.17% (+$90.0K) YoY NEW(+$7.7M)
CG Oncology, Inc.(CGONcusip156944100)	301.1K	QoQ +39.57% (+85.4K) YoY +14589.46% (+299.1K)	All Managers (Combined)	$7.4M	1.4% ($7.4M/$523.7M)	QoQ +19.18% (+$1.2M) YoY +8094.64% (+$7.3M)
RAPT Therapeutics, Inc.(RAPTcusip75382E109)	6.0M	QoQ +408.44% (+4.8M) YoY +79510.24% (+6.0M)	All Managers (Combined)	$7.3M	1.4% ($7.3M/$523.7M)	QoQ +292.59% (+$5.4M) YoY +10715.64% (+$7.2M)
Janux Therapeutics, Inc.(JANXcusip47103J105)	264.9K	QoQ +740.71% (+233.4K) YoY +1792.14% (+250.9K)	All Managers (Combined)	$7.2M	1.4% ($7.2M/$523.7M)	QoQ +323.96% (+$5.5M) YoY +1256.91% (+$6.6M)
Arbutus Biopharma Corp(ABUScusip03879J100)	1.9M	QoQ +20.85% (+324.3K) YoY -9.40% (-195.1K)	All Managers (Combined)	$6.6M	1.3% ($6.6M/$523.7M)	QoQ +28.98% (+$1.5M) YoY +22.54% (-$1.2M)
(cusip46116X101)✕	48.0K	QoQ NEW(+48.0K) YoY NEW(+48.0K)	All Managers (Combined)	$6.3M	1.2% ($6.3M/$523.7M)	QoQ NEW(+$6.3M) YoY NEW(+$6.3M)